Voie d'immunisation et séquence d'administration de l ... - TEL
Voie d'immunisation et séquence d'administration de l ... - TEL
Voie d'immunisation et séquence d'administration de l ... - TEL
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
tel-00827710, version 1 - 29 May 2013<br />
III. COMBINATION OF ANTIGEN WITH ADJUVANT<br />
A. The timing of adjuvant <strong>de</strong>livery should be coordinated with<br />
antigen processing and presentation<br />
1) Effects of poly I:C and type I IFN in our mo<strong>de</strong>l<br />
Adjuvants and more specifically type I IFN can impact CD8 + T cell cross-priming in a vari<strong>et</strong>y<br />
of ways. In our specific mo<strong>de</strong>l we <strong>de</strong>monstrated that the optimal timing of adjuvant <strong>de</strong>livery<br />
is immunization route-<strong>de</strong>pen<strong>de</strong>nt (Figure 37). Moreover, for the optimal benefit,<br />
administration should be closely coordinated with the timing of antigen uptake and<br />
presentation, as <strong>de</strong>livery that occured too early inhibited subsequent priming while late<br />
<strong>de</strong>livery enhanced it (Figure 38). These effects of poly I:C were shown to be type I IFN-<br />
<strong>de</strong>pen<strong>de</strong>nt (Figures 41 and 46). Specifically, we observed that poly I:C and type I IFN act at<br />
several levels. From these results, we propose a mo<strong>de</strong>l for adjuvant action and timing of<br />
<strong>de</strong>livery that illustrates how these diverse effects can impact cross-priming, based on the<br />
kin<strong>et</strong>ic of antigen uptake, processing and presentation in both a positive or negative fashion.<br />
Figure 52 recapitulates these points in different experimental conditions: (A) absence of<br />
adjuvant, (B) early adjuvant <strong>de</strong>livery, (C) late adjuvant <strong>de</strong>livery.<br />
In our mo<strong>de</strong>l of immunization with cell-associated antigen, in combination with poly I:C<br />
adjuvant <strong>de</strong>livery, we observed:<br />
- A substantial recruitment of DCs into the draining lymph no<strong>de</strong> (Figure 43A). If<br />
these cells have already phagocytosed antigen, this recruitment can be consi<strong>de</strong>red<br />
to have a positive effect for cross-priming, as it may increase the amount of<br />
antigen reaching the draining lymph no<strong>de</strong>. In contrast, if antigen has not y<strong>et</strong> been<br />
engulfed, then this flow of DCs to lymph no<strong>de</strong> results in the removal of them from<br />
the skin, ren<strong>de</strong>ring them no longer capable of phagocytosing antigen (Figure 52,<br />
(1)).<br />
- In parallel, poly I:C treatment induced DC maturation (Figure 43B). Again, this<br />
process will potentiate cross-priming if the antigen has already been phagocytosed,<br />
by improving the ability of DCs to activate T cells. However, if these maturation<br />
signals arrive before antigen engulfment, DC maturation would lead to<br />
downregulation of antigen capture ability and inhibition of cross-presentation<br />
(Figure 52, (2)).<br />
- We observed the disappearance of CD8α + DCs upon poly I:C stimulation (Figures<br />
43 and 44), which may be due to <strong>de</strong>ath of this cell subs<strong>et</strong>. As these cells are<br />
154